Objective: To develop a valid, reliable, and sensitive self-administered questionnaire in Spanish to measure the knowledge asthmatic patients have of their disease.
Patients And Methods: The face and content validity of the questions was established by consensus among expert pulmonologists. To determine the importance of the questions, they were put to 100 participating asthmatic patients. The number of questions was reduced by consensus taking into account the importance given to each question by these patients. A further 25 patients participated in the assessment of reliability and sensitivity. The questionnaire was administered 5 times: twice before and 3 times after an educational intervention. The direct and indirect external consistency (kappa statistic) and the overall kappa value were determined. Sensitivity was assessed from the number of correct answers before and after the intervention (Wilcoxon test; P< .05) and from the percentage change (>40% was clinically significant).
Results: Fifty-nine questions were drawn up and the final version included 20. The test-retest consistency was between 0.81 and 1 in 76% of the cases before the intervention and in 92% after it. The kappa statistic before the intervention was between 0.41 and 1 in 96% of the cases, and between 0.81 and 1 in 88% afterwards. The overall kappa values before and after the intervention were 0.12 and 0.43, respectively. The median sensitivity, measured as percentage change, was 67% and 10 patients showed an improvement between 81% and 233%.
Conclusions: The questionnaire is reliable, has face and content validity, and is very sensitive to change. In view of these results, this instrument is useful for measuring the knowledge that asthmatic patients have of their disease in clinical practice and investigation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s1579-2129(07)60062-7 | DOI Listing |
Adv Ther
January 2025
Department of Endocrinology and Nutrition, Hospital Universitari de Bellvitge-IDIBELL, C/de la Feixa Llarga S/N, 08907, Hospitalet de Llobregat, Barcelona, Spain.
Introduction: Obesity and its complications are associated with high morbidity/mortality and a significant healthcare cost burden in Spain. It is therefore essential to know the potential clinical and economic benefits of reducing obesity. The objective of this study is to predict the decrease in rates of onset of potential complications associated with obesity and the cost savings after a weight loss of 15% over 10 years in Spain.
View Article and Find Full Text PDFExpert Rev Respir Med
January 2025
Fondazione Istituto "G. Giglio" Cefalù, Cefalù, Italy.
Introduction: To evaluate the effectiveness of noninvasive positive pressure ventilation (NPPV) versus standard therapy in severe asthma exacerbations through meta-analysis.
Methods: Nine randomized controlled trials (344 patients) were analyzed from inception to August 2024. Primary outcomes included respiratory rate, forced expiratory volume in first second (FEV1), and oxygen saturation (SpO2).
BMC Public Health
January 2025
Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Background: Chronic respiratory diseases (CRD) represents a series of lung disorders and is posing a global health burden. Systemic inflammation and phenotypic ageing have been respectively reported to associate with certain CRD. However, little is known about the co-exposures and mutual associations of inflammation and ageing with CRD.
View Article and Find Full Text PDFNPJ Prim Care Respir Med
January 2025
Erasmus MC, Department of General Practice, Rotterdam, The Netherlands.
Asthma and allergic rhinitis (AR) are common disorders of the respiratory tract that often coincide. Control of AR symptoms can improve asthma outcomes in patients with co-existing diseases. Our aim is to produce a systematic review of the effectiveness of conventional anti-AR medication for asthma outcomes in patients with both diseases.
View Article and Find Full Text PDFProg Mol Biol Transl Sci
January 2025
Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea; College of Medicine, Hanyang University, Seoul, Korea. Electronic address:
Genetic and environmental factors can have an impact on lung and respiratory disorders which are associated with severe symptoms and have high mortality rates. Many respiratory diseases are significantly influenced by genetic or epigenetic factors. Gene therapy offers a powerful approach providing therapeutic treatment for lung diseases.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!